Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells

Morgane Bomsel(Centre National de la Recherche Scientifique), Lucia Lopalco(Vita-Salute San Raffaele University), Daniela Tudor(Délégation Paris 5), S. Morgado Garcia(Vita-Salute San Raffaele University), Claudia Pastori(Vita-Salute San Raffaele University), Davide Ferrari(University of Modena and Reggio Emilia), Chiara Alberti(Vita-Salute San Raffaele University), Adriano Lazzarin(Vita-Salute San Raffaele University)
AIDS
December 4, 2006
10.1097/qad.0b013e328011049b
Cited by 46

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Control of HIV despite the Discontinuation of Antiretroviral Therapy
|New England Journal of Medicine|1999|328
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
|Immunity|2011|285